KA
CVS icon

Kovack Advisors’s CVS Health CVS Stock Holding History

Kovack Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$898K Sell
12,425
-1,669
-12% -$129K 0.05% 400
2025
Q4 		$1.12M Buy
14,094
+6,100
+76% +$481K 0.05% 338
2025
Q3 		$603K Buy
7,994
+82
+1% +$5.62K 0.06% 286
2025
Q2 		$546K Sell
7,912
-2,759
-26% -$181K 0.05% 304
2025
Q1 		$723K Sell
10,671
-269
-2% -$16.1K 0.08% 224
2024
Q4 		$491K Buy
10,940
+2,078
+23% +$117K 0.05% 307
2024
Q3 		$557K Sell
8,862
-34
-0.4% -$1.98K 0.06% 281
2024
Q2 		$525K Sell
8,896
-18,065
-67% -$1.13M 0.06% 296
2024
Q1 		$2.15M Buy
26,961
+1,683
+7% +$129K 0.26% 81
2023
Q4 		$2M Buy
25,278
+10,050
+66% +$715K 0.24% 94
2023
Q3 		$1.06M Buy
15,228
+2,312
+18% +$164K 0.15% 144
2023
Q2 		$893K Buy
12,916
+3,006
+30% +$214K 0.11% 171
2023
Q1 		$736K Buy
9,910
+95
+1% +$7.97K 0.1% 206
2022
Q4 		$915K Sell
9,815
-1,130
-10% -$109K 0.13% 158
2022
Q3 		$1.04M Buy
10,945
+141
+1% +$14K 0.15% 147
2022
Q2 		$1M Sell
10,804
-2,073
-16% -$202K 0.13% 163
2022
Q1 		$1.3M Buy
12,877
+1,695
+15% +$178K 0.13% 164
2021
Q4 		$1.15M Buy
11,182
+3,231
+41% +$299K 0.11% 196
2021
Q3 		$675K Sell
7,951
-33
-0.4% -$2.76K 0.07% 299
2021
Q2 		$666K Buy
7,984
+40
+0.5% +$3.28K 0.08% 285
2021
Q1 		$598K Sell
7,944
-20
-0.3% -$1.46K 0.08% 277
2020
Q4 		$544K Sell
7,964
-467
-6% -$30.4K 0.08% 264
2020
Q3 		$492K Buy
8,431
+831
+11% +$51.7K 0.09% 225
2020
Q2 		$494K Buy
7,600
+1,511
+25% +$95.2K 0.1% 216
2020
Q1 		$361K Sell
6,089
-2,592
-30% -$173K 0.08% 251
2019
Q4 		$651K Sell
8,681
-630
-7% -$44.2K 0.12% 194
2019
Q3 		$587K Sell
9,311
-786
-8% -$46.6K 0.12% 199
2019
Q2 		$550K Sell
10,097
-7,885
-44% -$425K 0.13% 197
2019
Q1 		$970K Buy
17,982
+2,718
+18% +$168K 0.24% 109
2018
Q4 		$1M Sell
15,264
-2,595
-15% -$194K 0.29% 83
2018
Q3 		$1.41M Sell
17,859
-89
-0.5% -$6.36K 0.36% 74
2018
Q2 		$1.16M Sell
17,948
-1,163
-6% -$76.6K 0.32% 75
2018
Q1 		$1.19M Buy
19,111
+4,819
+34% +$346K 0.3% 76
2017
Q4 		$1.04M Sell
14,292
-3,470
-20% -$252K 0.26% 87
2017
Q3 		$1.44M Buy
17,762
+3,431
+24% +$271K 0.48% 42
2017
Q2 		$1.15M Buy
14,331
+3,062
+27% +$242K 0.36% 56
2017
Q1 		$885K Buy
11,269
+525
+5% +$41.9K 0.34% 62
2016
Q4 		$848K Buy
10,744
+2,622
+32% +$212K 0.4% 53
2016
Q3 		$723K Buy
8,122
+1,248
+18% +$118K 0.35% 73
2016
Q2 		$658K Buy
6,874
+182
+3% +$18.1K 0.35% 67
2016
Q1 		$694K Sell
6,692
-680
-9% -$66.1K 0.43% 59
2015
Q4 		$721K Buy
7,372
+1,702
+30% +$167K 0.48% 54
2015
Q3 		$547K Sell
5,670
-1,721
-23% -$181K 0.38% 68
2015
Q2 		$775K Buy
7,391
+2,144
+41% +$219K 0.55% 42
2015
Q1 		$541K Buy
5,247
+2,394
+84% +$242K 0.46% 51
2014
Q4 		$275K Buy
+2,853
New +$251K 0.28% 94

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kovack Advisors's CVS Position: Q1 2026 in Review

Kovack Advisors reduced its CVS Health (CVS) stake by 12% in Q1 2026, selling an estimated $129K and leaving 12,425 shares worth $898K. The position accounts for 0.05% of the portfolio, ranked #400.

Kovack Advisors first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.15M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Kovack Advisors held 12,425 shares of CVS Health worth $898K as of Q1 2026.
  • Kovack Advisors sold 1,669 CVS Health shares in Q1 2026, an estimated $129K.
  • CVS Health made up 0.05% of Kovack Advisors's portfolio in Q1 2026, its #400 holding.
  • Kovack Advisors first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
  • Kovack Advisors's CVS Health position peaked at $2.15M in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.